HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 210 filers reported holding HORIZON PHARMA PLC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $49,650,000 | -72.6% | 3,359,258 | -70.0% | 2.73% | -68.8% |
| Q4 2016 | $180,998,000 | -4.6% | 11,186,518 | +6.9% | 8.75% | +0.6% |
| Q3 2016 | $189,777,000 | +91.6% | 10,467,603 | +74.1% | 8.70% | +59.8% |
| Q2 2016 | $99,029,000 | +191.3% | 6,012,667 | +193.1% | 5.45% | +191.4% |
| Q1 2016 | $33,990,000 | -60.1% | 2,051,275 | -47.8% | 1.87% | -54.9% |
| Q4 2015 | $85,162,000 | +28.1% | 3,929,955 | +17.2% | 4.14% | +29.2% |
| Q3 2015 | $66,489,000 | -54.7% | 3,354,634 | -20.6% | 3.21% | -44.1% |
| Q2 2015 | $146,805,000 | +14.3% | 4,225,829 | -14.6% | 5.74% | +5.3% |
| Q1 2015 | $128,478,000 | +56.4% | 4,947,140 | -22.4% | 5.45% | +52.6% |
| Q4 2014 | $82,169,000 | +99.9% | 6,374,616 | +90.4% | 3.57% | +93.3% |
| Q3 2014 | $41,109,000 | – | 3,347,604 | – | 1.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
| SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
| JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
| Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
| Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
| Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
| Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
| KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |